Adenosine A2B receptor modulates intestinal barrier function under hypoxic and ischemia/reperfusion conditions

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2006-2018

  Yang, Yang ^a   Qiu, Yuan ^a   Wang, Wensheng ^a   Xiao, Weidong ^a   Liang, Hongyin ^a   Zhang, Chaojun ^a   Yang, Hanwenbo ^b   Teitelbaum, Daniel H ^b   Sun, Li Hua ^a   Yang, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adenosine A2B receptor; Claudin 1; Hypoxia; Ischemia reperfusion; Occludin; TER; Tight junction; ZO 1

Indexed keywords

ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; MESSENGER RNA; TIGHT JUNCTION PROTEIN;

ACUTE DISEASE; ANIMAL; ANOXIA; C57BL MOUSE; CACO 2 CELL LINE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; IMPEDANCE; MALE; METABOLISM; PERMEABILITY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SMALL INTESTINE; TIGHT JUNCTION; TIME; VASCULARIZATION;

ACUTE DISEASE; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; ANOXIA; CACO-2 CELLS; DISEASE MODELS, ANIMAL; ELECTRIC IMPEDANCE; HUMANS; INTESTINE, SMALL; MALE; MICE, INBRED C57BL; PERMEABILITY; RECEPTOR, ADENOSINE A2B; REPERFUSION INJURY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; TIME FACTORS;

EID: 84902449051     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Daniel C, Sartory NA, Zahn N, Radeke HH and Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33.
2. Higuchi S, Wu R, Zhou M, Marini CP, Ravikumar TS and Wang P. Gut hyperpermiability after ischemia and reperfusion: attenuation with adrenomedullin and its binding protein treatment. Int J Clin Exp Pathol 2008; 1: 409-418.
3. Berland T and Oldenburg WA. Acute mesenteric ischemia. Curr Gastroenterol Rep 2008; 10: 341-346.
4. Ogra PL and Welliver RC Sr. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. Nestle Nutr Workshop Ser Pediatr Program 2008; 61: 145-181.
5. Kenway-Lynch CS, Das A, Pan D, Lackner AA and Pahar B. Dynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus Infection. J Virol 2013; 87: 11916-11923.
6. Visco V, Belleudi F, Marchese C, Leone L, Aimati L, Cardinali G, Kovacs D, Frati L and Torrisi MR. Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 2004; 200: 31-44.
7. Fukumoto S. [Disorders of phosphate metabolism]. Rinsho Byori 2010; 58: 225-231.
8. Tatekawa Y, Kanehiro H and Nakajima Y. Duodenal atresia associated with "apple peel" small bowel without deletion of fibroblast growth factor-10 or fibroblast growth factor receptor 2IIIb: report of a case. Surg Today 2007; 37: 430-433.
9. Mallick IH, Yang WX, Winslet MC and Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49: 1359-77.
10. Gonzalez-Mariscal L, Betanzos A, Nava P and Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003; 81: 1-44.
11. Gonzalez-Mariscal L, Tapia R and Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008; 1778: 729-756.
12. Edelblum KL and Turner JR. The tight junction in inflflammatory disease: communication breakdown. Curr Opin Pharmacol 2009; 9: 715-720.
13. Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO and Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 1998; 43: 435-441.
14. Li QR, Zhang Q, Wang CY, Liu XX, Qu LL, Gu LL, Li N and Li JS. Altered distribution of tight junction proteins after intestinal ischaemia/reperfusion injury in rats. J Cell Mol Med 2009; 13: 4061-4076.
15. Trowbridge JM, Rudisill JA, Ron D and Gallo RL. Dermatan sulfate binds and potentiates activity of keratinocyte growth factor (FGF-7). J Biol Chem 2002; 277: 42815-42820.
16. Kong T, Westerman KA, Faigle M, Eltzschig HK and Colgan SP. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 2006; 20: 2242-2250.
17. Hart ML, Henn M, Kohler D, Kloor D, Mittelbronn M, Gorzolla IC, Stahl GL and Eltzschig HK. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 2008; 22: 2784-2797.
18. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD and Ravid K. The A2B adenosine receptor protects against inflflammation and excessive vascular adhesion. J Clin Invest 2006; 116: 1913-1923.
19. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF and Eltzschig HK. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 2008; 111: 2024-2035.
20. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC and Colgan SP. Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004; 200: 1395-1405.
21. Kolachala V, Ruble B, Vijay-Kumar M, Wang L, Mwangi S, Figler H, Figler R, Srinivasan S, Gewirtz A, Linden J, Merlin D and Sitaraman S. Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol 2008; 155: 127-137.
22. Carman AJ, Mills JH, Krenz A, Kim DG and Bynoe MS. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci 2011; 31: 13272-13280.
23. Taraban VY, Slebioda TJ, Willoughby JE, Buchan SL, James S, Sheth B, Smyth NR, Thomas GJ, Wang EC and Al-Shamkhani A. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol 2011; 4: 186-196.
24. Smith PL. Methods for evaluating intestinal permeability and metabolism in vitro. Pharm Biotechnol 1996; 8: 13-34.
25. Weissmuller T, Eltzschig HK and Colgan SP. Dynamic purine signaling and metabolism during neutrophil-endothelial interactions. Purinergic Signal 2005; 1: 229-239.
26. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC and Colgan SP. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003; 198: 783-796.
27. Eltzschig HK, Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K and Ravid K. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. Plos Medicine 2008; 5: 968-986.
28. Marchiando AM, Graham WV and Turner JR. Epithelial Barriers in Homeostasis and Disease. Annu Rev Pathol 2010; 5: 119-144.
29. Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs AR and Davis TP. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J Cell Sci 2003; 116: 693-700.
30. Brown RC and Davis TP. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun 2005; 327: 1114-1123.
31. Yamagata K, Tagami M, Takenaga F, Yamori Y and Itoh S. Hypoxia-induced changes in tight junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. Neurobiol Dis 2004; 17: 491-499.
32. Brandt LJ and Boley SJ. AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology 2000; 118: 954-968.
33. Debus ES, Muller-Hulsbeck S, Kolbel T and Larena-Avellaneda A. Intestinal ischemia. Int J Colorectal Dis 2011; 26: 1087-1097.
34. Halm MA. Acute gastrointestinal complications after cardiac surgery. Am J Crit Care 1996; 5: 109-118; 119-120.
35. Faioni EM, Ferrero S, Fontana G, Gianelli U, Ciulla MM, Vecchi M, Saibeni S, Biguzzi E, Cordani N, Franchi F, Bosari S and Cattaneo M. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflflammatory bowel disease. Crit Care Med 2004; 32: 266-270.
36. Eltzschig HK, Thompson LF, Karhausen J, Cotta RJ, Ibla JC, Robson SC and Colgan SP. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004; 104: 3986-3992.
37. Jacobson KA and Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006; 5: 247-264.
38. Strohmeier GR, Reppert SM, Lencer WI and Madara JL. The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 1995; 270: 2387-2394.
39. Fischer S, Wiesnet M, Marti HH, Renz D and Schaper W. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol 2004; 198: 359-369.
40. Stenfeldt AL and Wenneras C. Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils. Immunology 2004; 112: 605-614.
41. Feoktistov I, Ryzhov S, Zhong H, Goldstein AE, Matafonov A, Zeng D and Biaggioni I. Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 2004; 44: 649-654.
42. Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W and Villarreal F. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2004; 287: 2478-2486.